593 — Trenton, New Jersey

593 is a clinical research site located in Trenton, New Jersey, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

593 has participated in 1 clinical trials.

Therapeutic areas: Systemic Lupus Erythematosus.

Sponsors: UCB Pharma.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Trenton

Browse all research sites in New Jersey · View every site in Trenton

• Capital Health Hospital
• St. Francis Medical Center
• Premier Research
• Fox Chase Cancer Center at St. Francis Medical Center
• Research Site
• Pfizer Investigational Site
• Novo Nordisk Investigational Site
• Capital Health System at Mercer
• Capital Health System
• Capital Health Regional Medical Center
• Marc Seelagy, M.D.
• Saint Francis Medical Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 593?

593 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 593 conducted?

593 has 1 clinical trials on record. Their work covers Systemic Lupus Erythematosus.

Is 593 accredited by Crixeo Clinical Trials?

593 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 593?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.